Project Grant 2423489
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Awardee
Tissueform, Inc. (H25TERHQ5S68)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Boulder, CO 80304, USA
Similar Awards
This SBIR Phase I project, funded by the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), focuses on developing an innovative bioprinting approach to create vascular grafts that closely mimic the properties of natural blood vessels. The project aims to overcome the limitations of current synthetic and biological grafts by utilizing a specialized bioprinting process that integrates a double-network hydrogel made from a Dacron synthetic...
Biosapien Inc. received a $256,000 Project Grant award from the National Science Foundation on May 1, 2021 to develop a novel 3D printed biodegradable mesh delivering active pharmaceutical ingredients in a sustained and localized manner under the Small Business Innovation Research Phase I program. The SBIR Phase I grant supports the proof-of-concept stage of developing Biosapien's technology, with the work expected to be completed by June 30, 2022. The NSF Technology, Innovation, and...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) project grant, awarded to Meteora3D, Inc., will develop a rapid lift-based peel separation masked inverted stereolithography 3D printing technology for urgent procedural planning. The $275,000 award, effective December 1, 2024 through November 30, 2025, aims to advance scientific understanding and technological capabilities of desktop inverted vat...
This Small Business Innovation Research (SBIR) Phase II award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) provides $1,241,749 to Freescale LLC (doing business as Neuraink, Neurainc, Neuroinc, Neuroink, Brainc.) to scale a proprietary, multifunctional printing platform that deposits conductive, sensing, and non-volatile-memory nanocomposite inks onto rigid and flexible substrates with sub-micron features. The project aims to develop a compact,...
This National Science Foundation (NSF) Early-Concept Grant for Exploratory Research (EAGER) project, funded under the Engineering (CFDA 47.041) program, aims to establish a new embedded section-by-section bioprinting process to enable the fabrication of large-scale human tissue constructs with high cell viability. The $150,000 award, effective August 1, 2025 through July 31, 2027, will be executed by the University of Nevada, Reno. The key objectives are to identify cell damage mechanisms in the...
This $256,000 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program will support the development of additive manufacturing techniques for soft tissue repair. Asante Bio LLC will receive funding to design and engineer a novel 3D microfiber printer capable of assembling synthetic biopolymer filaments into fibrous, flexible implants that promote soft tissue healing. Through this six-month award ending November 2022, Asante Bio will optimize...
This $305,394 Project Grant award was made by the National Science Foundation's Engineering program (CFDA 47.041) to the University of Houston System to develop a hybrid bioprinting technology that can produce capillary-incorporated tissue constructs for regenerative medicine. The project aims to create three-dimensional biological scaffolds integrated with biomimetic microtubes to deliver nutrients and oxygen to cells, addressing a critical need in bioprinting large functional tissues. In...
The National Science Foundation (NSF) awarded a $149,826 Early-Concept Grants for Exploratory Research (EAGER) Project Grant to the University of Nebraska Medical Center (UNMC) under the NSF Engineering program (CFDA 47.041). The grant supports research to establish a new "embedded section-by-section bioprinting" process for fabricating large-scale human tissue constructs with high initial cell viability, exceeding 80% for constructs over 20mm. Key objectives include identifying cell...
This STTR Phase I project, funded by the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop a novel bioactive hydrogel dressing with a porous surface for the treatment of second-degree burn wounds. The $305,000 award to LF Printech LLC, a minority-owned, for-profit small business, seeks to address the critical challenges in burn wound management by creating a dressing that can accelerate natural healing processes, reduce pain...
The National Science Foundation (NSF) awarded a $305,000 Small Business Innovation Research (SBIR) Phase I grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Novaurum Biosciences Incorporated in Somerville, MA. The project aims to develop a novel mammalian cell-based nano-biological coating for implantable medical devices that can inhibit biofilm formation and protect against bacterial infections, including antibiotic-resistant strains, while promoting...